TickerFacts.

Niagen Bioscience, Inc. (NAGE): Share Repurchases

Annual figures by period end, from SEC filings.

$251.0K
Year ended 2025-12-31
$5.37M
Trailing 12 months to 2026-06-30
$404.0K2012-12-29: -$8.2K2017-12-30: $02018-12-31: $404.0K2024-12-31: $02025-12-31: $251.0K$251.0K
2012-12-29 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$251.0Kn/a2026-03-04, From 2025-01-01
2024-12-31$0n/a2026-03-04, From 2024-01-01
No annual figure between 2018-12-31 and 2024-12-31.
2018-12-31$404.0Kn/a2019-03-07, From 2017-12-31
2017-12-30$0n/a2019-03-07, From 2017-01-01
No annual figure between 2012-12-29 and 2017-12-30.
2012-12-29-$8.2Kn/a2014-03-27, From 2012-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Niagen Bioscience, Inc. (NAGE)2025-12-31$251.0Kn/a
Natural Alternatives International Inc (NAII)2025-06-30$178.0K-19.5%
Cronos Group Inc. (CRON)2025-12-31$9.74Mn/a
Mannatech Inc (MTEX)2024-12-31$0-100.0%
biote Corp. (BTMD)2025-12-31$3.37M-39.9%
C21 Investments Inc. (CWLXF)2026-03-31$103.0K-62.8%
USANA Health Sciences Inc (USNA)2026-01-03$27.51M+191.3%

Compare NAGE, NAII, CRON, MTEX side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗